Picture of Ascendis Pharma A/S logo

ASND — Ascendis Pharma A/S Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapMomentum Trap

Momentum

Relative Strength (%)
1m-12.5%
3m-7.16%
6m-26.54%
1yr-28.18%
Volume Change (%)
10d/3m+63.62%
Price vs... (%)
52w High-49.47%
50d MA-12.54%
200d MA-29.95%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-35.51%
Return on Equity-60.49%
Operating Margin-3284.06%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for ASND

Will the Ascendis Pharma A/s share price run continue? background image

Will the Ascendis Pharma A/s share price run continue?

In this article we will quickly re-cap the broker forecasts for Ascendis Pharma A/s (NSQ:ASND). The Ascendis Pharma A/s share price has risen by 13.9% over the past month and it’s currently trading at 146. For investors considering whe...

What does the future hold for the Ascendis Pharma A/s share price? background image

What does the future hold for the Ascendis Pharma A/s share price?

The Ascendis Pharma A/s (NSQ:ASND) share price has risen by 10.2% over the past month and it’s currently trading at 140.77. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run wi...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Ascendis Pharma A/S EPS forecast chart

Profile Summary

ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company, which is involved in manufacture products for rare diseases. The Company utilizes its TransCon technologies for treatment, which can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs. The Company is headquartered in Copenhagen, Denmark with offices in Heidelberg, Germany and Palo Alto, California.

Directors

Last Annual
December 31st, 2021
Last Interim
March 31st, 2022
Incorporated
September 21st, 2006
Public Since
January 28th, 2015
No. of Shareholders
3
No. of Employees
639
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
56,958,391
Blurred out image of a map
Address
Tuborg Boulevard 12, HELLERUP, 2900
Web
https://ascendispharma.dk/
Phone
Contact
Scott Smith
Auditors
Deloitte Statsautoriseret Revisionspartnerselskab

ASND Share Price Performance

Upcoming Events for ASND

Q2 2022 Ascendis Pharma A/S Earnings Release

Q3 2022 Ascendis Pharma A/S Earnings Release

Similar to ASND

Picture of 2Seventy Bio logo

2Seventy Bio

us flag iconNASDAQ Global Select Market

Picture of 4D Molecular Therapeutics logo

4D Molecular Therapeutics

us flag iconNASDAQ Global Select Market

Picture of AbCellera Biologics logo

AbCellera Biologics

us flag iconNASDAQ Global Select Market

Picture of AbSci logo

AbSci

us flag iconNASDAQ Global Select Market

Picture of ACADIA Pharmaceuticals logo

ACADIA Pharmaceuticals

us flag iconNASDAQ Global Select Market

FAQ

Or unlock with your email

Or unlock with your email